GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Long-Term Debt

4basebio (XTER:88Q) Long-Term Debt : €0.00 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Long-Term Debt?

4basebio's Long-Term Debt for the quarter that ended in Jun. 2023 was €0.00 Mil.

4basebio's quarterly Long-Term Debt increased from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€2.78 Mil) but then declined from Dec. 2022 (€2.78 Mil) to Jun. 2023 (€0.00 Mil).

4basebio's annual Long-Term Debt declined from Dec. 2020 (€1.36 Mil) to Dec. 2021 (€1.01 Mil) but then increased from Dec. 2021 (€1.01 Mil) to Dec. 2022 (€2.78 Mil).


4basebio Long-Term Debt Historical Data

The historical data trend for 4basebio's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Long-Term Debt Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Long-Term Debt
2.53 1.36 1.01 2.78

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Long-Term Debt Get a 7-Day Free Trial - 1.01 - 2.78 -

4basebio  (XTER:88Q) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


4basebio Long-Term Debt Related Terms

Thank you for viewing the detailed overview of 4basebio's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


4basebio (XTER:88Q) Business Description

Traded in Other Exchanges
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines